These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24261626)

  • 21. [The diagnostic significance of finding a M-component in serum].
    Schmidt EB; Møller-Petersen J
    Ugeskr Laeger; 1986 Mar; 148(11):633-5. PubMed ID: 3083549
    [No Abstract]   [Full Text] [Related]  

  • 22. Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Willrich MAV; Murray DL; Kyle RA
    Clin Biochem; 2018 Jan; 51():38-47. PubMed ID: 28479151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
    Stelmach-Gołdyś A; Czarkowska-Paczek B
    Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple myeloma precursor disease: current clinical and epidemiological insights and future opportunities.
    Landgren O; Korde N
    Oncology (Williston Park); 2011 Jun; 25(7):589-90. PubMed ID: 21888256
    [No Abstract]   [Full Text] [Related]  

  • 25. [Benign monoclonal gammopathies].
    Sibilia J; Fermand JP
    Rev Prat; 1993 Feb; 43(3):289-92. PubMed ID: 8502957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Benign monoclonal gammopathy].
    Shirota T; Kondo M; Uchida H; Ito H
    Nihon Rinsho; 1995 Mar; 53(3):720-4. PubMed ID: 7699912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120).
    Papanikolaou X; Rosenthal A; Dhodapkar M; Epstein J; Khan R; van Rhee F; Jethava Y; Waheed S; Zangari M; Hoering A; Crowley J; Alapat D; Davies F; Morgan G; Barlogie B
    Blood Cancer J; 2016 Mar; 6(3):e410. PubMed ID: 27015287
    [No Abstract]   [Full Text] [Related]  

  • 28. [Multiple myeloma and idiopathic monoclonal gammapathy. Diagnosis, prognosis and treatment].
    Bladé J
    Med Clin (Barc); 1988 Apr; 90(17):704-14. PubMed ID: 3045448
    [No Abstract]   [Full Text] [Related]  

  • 29. [Spectrum of monoclonal gammopathies].
    Matuszkiewicz-Rowińska J; Wieliczko M
    Wiad Lek; 2017; 70(6 pt 2):1170-1174. PubMed ID: 29533907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma in Older Adults.
    Guerard EJ; Tuchman SA
    Clin Geriatr Med; 2016 Feb; 32(1):191-205. PubMed ID: 26614868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Monoclonal gammopathy of undetermined significance].
    Chaïbi P; Merlin L; Thomas C; Piette F
    Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Stratification of Precursors to Multiple Myeloma in 2020.
    Chudasama R; Barth P
    R I Med J (2013); 2020 Apr; 103(3):46-47. PubMed ID: 32236162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal gammopathy of undetermined significance.
    Kyle RA; Rajkumar SV
    Br J Haematol; 2006 Sep; 134(6):573-89. PubMed ID: 16938117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biochemical and immunological findings of multiple myeloma].
    Asaoku H
    Nihon Rinsho; 2007 Dec; 65(12):2256-60. PubMed ID: 18069270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum free light chain analysis in B-cell dyscrasias.
    Ramasamy I
    Ann Clin Lab Sci; 2007; 37(3):291-4. PubMed ID: 17709698
    [No Abstract]   [Full Text] [Related]  

  • 36. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study.
    Golombick T; Diamond TH; Manoharan A; Ramakrishna R
    Am J Hematol; 2012 May; 87(5):455-60. PubMed ID: 22473809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal gammopathies of undetermined significance.
    Kyle RA; Rajkumar SV
    Rev Clin Exp Hematol; 2002 Sep; 6(3):225-52. PubMed ID: 12616697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians.
    Caers J; Vekemans MC; Bries G; Beel K; Delrieu V; Deweweire A; Demuynck H; De Prijck B; De Samblanx H; Kentos A; Meuleman N; Mineur P; Offner F; Vande Broek I; Van Droogenbroeck J; Vande Velde A; Wu KL; Delforge M; Schots R; Doyen C;
    Ann Med; 2013 Sep; 45(5-6):413-22. PubMed ID: 23767978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The clinical significance of M proteins].
    Sasaki R
    Rinsho Byori; 2001 Jul; 49(7):678-81. PubMed ID: 11519130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New tools for detecting occult monoclonal gammopathy, a cause of secondary osteoporosis.
    Faiman B; Licata AA
    Cleve Clin J Med; 2010 Apr; 77(4):273-8. PubMed ID: 20360121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.